Ann Thorac Surg 1996;61:1445-1446
© 1996 The Society of Thoracic Surgeons
Discussion
Discussion
| The first 20% of the full text of this article appears below. |
See also page 1441.
DR MARK J. KRASNA (Baltimore, MD): I want to compliment Dr Reed on an excellent presentation and thank her and her coauthors for sending me their manuscript. At the University of Maryland, my pulmonary colleague, Dr Jonathan Orens, has just presented data on 80 patients in a prospective, randomized trial with endobronchial ultrasound and transbronchial needle aspiration. Basically we found that this was a very good way of minimizing the number of passes necessary to get a positive transbronchial needle aspiration, and it also allowed biopsy of lesions that were less than 1 cm in size, as opposed to the usual 1.5 cm by transbronchial needle aspiration.
As you know, we have described here and elsewhere the use of thoracoscopy in both lung and esophagus cancer for biopsy of mediastinal lymph nodes. I therefore have two questions.
First, it seems that in lung cancer, the primary areas that we are concerned with are the level 2 and 4 paratracheal lymph nodes and, as you mentioned, the subcarinal lymph nodes. These lymph nodes historically have been accessible by cervical mediastinoscopy, and I think you adequately showed that this technique, although useful for some lymph node stations, does in fact miss these paratracheal lymph nodes. I therefore wonder if you could put in perspective for us where this technique will fall . . . [Full Text of this Article]
Related Article
-
Endoscopic Ultrasound With Fine-Needle Aspiration in the Diagnosis and Staging of Lung Cancer
- Gerard A. Silvestri, Brenda J. Hoffman, Manoop S. Bhutani, Robert H. Hawes, Lynn Coppage, Angela Sanders-Cliette, and Carolyn E. Reed
Ann. Thorac. Surg. 1996 61: 1441-1445.
[Abstract]
[Full Text]
Copyright © 1996 by The Society of Thoracic Surgeons.
